Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial
Titel:
Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial
Auteur:
Urbonas, V. Schadendorf, D. Zimmer, L. Danson, S. Marshall, E. Corrie, P. Wheater, M. Plummer, E. Mauch, C. Scudder, C. Goff, M. Love, S.B. Mohammed, S.B. Middleton, M.R.